• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病中的微生物生态系统:对胃肠道系统的考量

Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System.

作者信息

Yehualashet Awgichew Shewasinad, Yikna Berhan Begashaw

机构信息

Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.

出版信息

Diabetes Metab Syndr Obes. 2021 Apr 28;14:1841-1854. doi: 10.2147/DMSO.S304497. eCollection 2021.

DOI:10.2147/DMSO.S304497
PMID:33953584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8089103/
Abstract

Intestinal microbiota is established to be a crucial element in the control of human health, and keeping the symbiotic relationship between the human body and intestinal microbes will have paramount importance. A number of investigations illustrated that many chronic diseases are associated with intestinal micro-ecological disorders implying intestinal floras as an important component among the environmental factors, and perturbations in their composition are correlated with metabolic disorders, including obesity and diabetes mellitus (DM). Increased evidence suggests that alterations in the gut microbial ecosystem have been involved in part in the pathogenesis of both type 1 and type 2 DM. Short chain fatty acids (SCFAs), derived from microbiota, have been studied for their potential action in modulating CNS, gut barrier axis, and the immune system as a promising mechanism for the observed protective effects on diabetes pathogenesis. Besides, the role of bile acid (BA) stimulated receptors to have a significant role in liver metabolism, and pathophysiology of liver-based metabolic diseases has also been investigated. In the current review, we will try to summarize the correlation between intestinal microbiota and diabetes considering the existing current evidence revealing the role of gut microbiota in onset and disease progression.

摘要

肠道微生物群已被确认为控制人类健康的关键因素,维持人体与肠道微生物之间的共生关系至关重要。大量研究表明,许多慢性疾病与肠道微生态紊乱有关,这意味着肠道菌群是环境因素中的重要组成部分,其组成的扰动与代谢紊乱相关,包括肥胖和糖尿病(DM)。越来越多的证据表明,肠道微生物生态系统的改变在1型和2型糖尿病的发病机制中都起到了一定作用。源自微生物群的短链脂肪酸(SCFAs)因其在调节中枢神经系统、肠道屏障轴和免疫系统方面的潜在作用而受到研究,这是其对糖尿病发病机制具有保护作用的一种有前景的机制。此外,胆汁酸(BA)刺激受体在肝脏代谢中的重要作用以及基于肝脏的代谢性疾病的病理生理学也已得到研究。在本综述中,我们将根据现有证据总结肠道微生物群与糖尿病之间的相关性,这些证据揭示了肠道微生物群在发病和疾病进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb97/8089103/134fe9805327/DMSO-14-1841-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb97/8089103/f380997f99e9/DMSO-14-1841-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb97/8089103/134fe9805327/DMSO-14-1841-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb97/8089103/f380997f99e9/DMSO-14-1841-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb97/8089103/134fe9805327/DMSO-14-1841-g0002.jpg

相似文献

1
Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System.糖尿病中的微生物生态系统:对胃肠道系统的考量
Diabetes Metab Syndr Obes. 2021 Apr 28;14:1841-1854. doi: 10.2147/DMSO.S304497. eCollection 2021.
2
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.短链脂肪酸:缓解应激诱导的脑肠轴改变的微生物代谢产物。
J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28.
3
Role of the gut microbiota in type 2 diabetes and related diseases.肠道微生物群在 2 型糖尿病及相关疾病中的作用。
Metabolism. 2021 Apr;117:154712. doi: 10.1016/j.metabol.2021.154712. Epub 2021 Jan 23.
4
Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet.肠道微生物群与1型糖尿病:地中海饮食的影响
Front Nutr. 2021 Jan 13;7:612773. doi: 10.3389/fnut.2020.612773. eCollection 2020.
5
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
6
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
7
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.连接免疫系统、系统性慢性炎症和肠道微生物组:性别的作用。
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
8
Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus.内分泌学机制:2 型糖尿病患者的肠道微生物群。
Eur J Endocrinol. 2015 Apr;172(4):R167-77. doi: 10.1530/EJE-14-0874. Epub 2014 Nov 21.
9
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus.二甲双胍对肥胖症和2型糖尿病患者肠道微生物群的影响。
Diabetes Metab Syndr Obes. 2020 Dec 16;13:5003-5014. doi: 10.2147/DMSO.S286430. eCollection 2020.
10
[Gut microbiota and immune crosstalk in metabolic disease].[代谢性疾病中的肠道微生物群与免疫相互作用]
Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6.

引用本文的文献

1
A Metabolite Perspective on the Involvement of the Gut Microbiota in Type 2 Diabetes.从代谢物角度探讨肠道微生物群在 2 型糖尿病中的作用。
Int J Mol Sci. 2023 Oct 8;24(19):14991. doi: 10.3390/ijms241914991.
2
Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.证据表明肠道菌群失调在糖尿病视网膜病变中的作用。
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):21. doi: 10.1167/iovs.63.8.21.
3
Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance.器官间串扰在肥胖相关胰岛素抵抗发展中的作用。

本文引用的文献

1
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.粪便微生物群移植在随机对照试验中阻止了人类新发 1 型糖尿病的进展。
Gut. 2021 Jan;70(1):92-105. doi: 10.1136/gutjnl-2020-322630. Epub 2020 Oct 26.
2
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.评估肠道微生物群在 1 型糖尿病中的因果作用及其可能的发病机制。
Front Endocrinol (Lausanne). 2020 Mar 24;11:125. doi: 10.3389/fendo.2020.00125. eCollection 2020.
3
Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion.
Handb Exp Pharmacol. 2022;274:205-226. doi: 10.1007/164_2021_564.
肠道微生物群衍生的短链脂肪酸(SCFAs)在胰腺 β 细胞生长和胰岛素分泌中的争议性作用。
Int J Mol Sci. 2020 Jan 30;21(3):910. doi: 10.3390/ijms21030910.
4
The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.核受体 FXR 可抑制细菌来源的短链脂肪酸对胰高血糖素样肽-1 的分泌。
Sci Rep. 2020 Jan 13;10(1):174. doi: 10.1038/s41598-019-56743-x.
5
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial.口服丁酸盐不会影响长期 1 型糖尿病患者的固有免疫和胰岛自身免疫:一项随机对照试验。
Diabetologia. 2020 Mar;63(3):597-610. doi: 10.1007/s00125-019-05073-8. Epub 2020 Jan 8.
6
The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases.肠道微生物群与自身免疫性疾病的动态相互作用。
J Immunol Res. 2019 Oct 27;2019:7546047. doi: 10.1155/2019/7546047. eCollection 2019.
7
Gastrointestinal Microbiota and Type 1 Diabetes Mellitus: The State of Art.胃肠道微生物群与1型糖尿病:现状
J Clin Med. 2019 Nov 2;8(11):1843. doi: 10.3390/jcm8111843.
8
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity.短链脂肪酸乙酸在体重控制和胰岛素敏感性中的作用。
Nutrients. 2019 Aug 18;11(8):1943. doi: 10.3390/nu11081943.
9
Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.2 型糖尿病与肠道菌群关系的研究进展。
Biomed Pharmacother. 2019 Sep;117:109138. doi: 10.1016/j.biopha.2019.109138. Epub 2019 Jun 24.
10
Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets.了解胆汁酸信号在糖尿病中的作用:从病理生理学到治疗靶点。
Diabetes Metab J. 2019 Jun;43(3):257-272. doi: 10.4093/dmj.2019.0043.